Nippon India Nifty Pharma ETF
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Nifty Pharma ETF
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Exchange Traded Funds (ETFs)
Launch Date
: 21-Jun-2021
Fund Manager
: Jitendra Tolani
Net Assets (Rs. cr)
: 887.84
Nippon India Nifty Pharma ETF - Nav Details
Nav Date
: 28-May-2025
NAV [Rs.]
: 21.8338
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
: Nil
Exit Load %
: Nil
Nippon India Nifty Pharma ETF- NAV Chart
Nippon India Nifty Pharma ETF- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -1.52 | -2.36 | 7.91 | -1.42 | 11.75 | 19.65 | - | 11.25 |
| Category Avg | 0.99 | 4.25 | 10.58 | 0.74 | 6.95 | 19.1 | 24.65 | 15.4 |
| Category Best | 7.92 | 30.09 | 64.36 | 31.34 | 37.59 | 41.88 | 43.4 | 453.24 |
| Category Worst | -2.99 | -1.4 | -14.22 | -14.27 | -12.56 | 7.48 | 4.97 | -26.02 |
Nippon India Nifty Pharma ETF- Latest Dividends
No Records Found
Nippon India Nifty Pharma ETF- Investment Details
Min. Investment(Rs.)
: 1000
Increm.Investment(Rs.)
: 0
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 25.53 | 1237230 | 226.69 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 11.27 | 645572 | 100.07 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 9.99 | 145720 | 88.69 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 9.33 | 700002 | 82.87 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 6.54 | 277176 | 58.08 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 4.49 | 120024 | 39.87 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 4.44 | 320932 | 39.44 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 3.60 | 129596 | 31.94 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 3.51 | 60972 | 31.19 |
| Equity | Laurus Labs | Pharmaceuticals & Biotechnology | 3.05 | 449094 | 27.11 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 2.87 | 286629 | 25.45 |
| Equity | Glenmark Pharma. | Pharmaceuticals & Biotechnology | 2.69 | 172769 | 23.86 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 2.52 | 159468 | 22.34 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.02 | 5980 | 17.93 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 1.87 | 516794 | 16.63 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 1.49 | 82294 | 13.26 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 1.47 | 48333 | 13.07 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 1.44 | 91313 | 12.78 |
| Equity | Natco Pharma | Pharmaceuticals & Biotechnology | 0.98 | 102691 | 8.73 |
| Equity | Granules India | Pharmaceuticals & Biotechnology | 0.85 | 166288 | 7.57 |
| Cash & Cash Equivalent | |||||
| Reverse Repo | TREPS | -/- | 0.04 | 0 | 0.35 |
| Net CA & Others | Net CA & Others | -/- | 0.01 | 0 | -0.19 |
| Cash & Cash Equivalent | C C I | -/- | 0.00 | 0 | 0.00 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
5,61,387.15
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Jitendra Tolani
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
